Clinical Trial Update: Expression of NIS Protein and mRNA in Thyroid Tumors

View source ↗

Summary

The document reports on a completed clinical trial evaluating expression of the sodium-iodide symporter (NIS) at the protein and mRNA levels in thyroid tumors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thyroid Neoplasms

Snippet

Sponsor: University of Sao Paulo | Conditions: Tumors | Status: COMPLETED